FDA Takes Action to Halt Marketing of Unapproved Ergotamine Companies
FDA Takes Action to Halt Marketing of Unapproved Ergotamine Companies Ordered to Cease Manufacturing and Distribution of Illegal Drugs to Treat Migraine Headaches
The Food and Drug Administration (FDA) today told 20 companies to cease marketing unapproved drug products containing ergotamine tartrate.